1. 19. The Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (HRQoL) of Patients with Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III, a Placebo-Controlled Clinical Trial. (4th December 2021) Authors: Hohmann, Elizabeth; Feuerstadt, Paul; Oneto, Caterina; Berenson, Charles; Lee, Christine; Pham, Sissi; Zhu, Lei; Reese, Pat Ray; Wu, Henry; Wang, Elaine E; Wang, Elaine E; von Moltke, Lisa; Garey, Kevin W Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 19. The Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (HRQoL) of Patients with Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III, a Placebo-Controlled Clinical Trial. (4th December 2021) Authors: Hohmann, Elizabeth; Feuerstadt, Paul; Oneto, Caterina; Berenson, Charles; Lee, Christine; Pham, Sissi; Zhu, Lei; Reese, Pat Ray; Wu, Henry; Wang, Elaine E; Wang, Elaine E; von Moltke, Lisa; Garey, Kevin W Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Validation of a Health-Related Quality of Life Questionnaire in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Phase 3 Randomized Trial. (5th July 2022) Authors: Lapin, Brittany; Garey, Kevin W; Wu, Henry; Pham, Sissi V; Huang, Shirley P; Reese, Pat Ray; Wang, Elaine; Deshpande, Abhishek Journal: Clinical infectious diseases Issue: Volume 76:Number 3(2023) Page Start: e1195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗